From obesity management programs to rebates and apps, employers are experimenting with new approaches to make GLP-1 costs more sustainable.
Articles
Posted inCost of Care
Should People Who Want GLP-1s Have to Work for Them?
As demand for new weight loss drugs soars, some employers are making workers track their diet and exercise in hopes of limiting use and keeping costs down.
Posted inHealth Law
How a Supreme Court Fight Over Fish Oil Could Raise Your Prescription Drug Costs
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
Posted inMental Health
A Better Way to Care for Older Adults with Opioid Addiction
How one addiction clinic in Baltimore has found success combining addiction care with support for the many other health problems older Americans often face.
Posted inPublic Health
Inside Maryland’s High-Stakes Bid for Trump’s $50 Billion Rural Health Fund
The White House asked states to compete for a rare pot of new money dedicated to transforming health care across rural America.
Posted inPublic Health
What You Need to Know About the New $50 Billion Rural Health Fund
The Trump administration recently announced how much money each state will receive under an ambitious 5-year initiative known as the Rural Health Transformation Program.
Posted inHealth Equity
Watch: The $50 Billion Rural Health Program in Context
Experts discuss what the new federal approach means for access, outcomes, and financial stability in rural America.
Posted inHealth Equity
Homeless Camp Sweeps Can Harm Health. Some Cities Are Trying a New Way.
Several cities and counties are addressing street homelessness with a new approach, which experts say can clear encampments while protecting the health of people who are forced to move.
Posted inCost of Care
What Would Actually Lower Drug Prices in America? Experts Weigh In
Some of America’s top scholars on prescription drug pricing outline steps the Trump administration could take to make medicines more affordable.
Posted inInsurance
Watch: Obamacare Subsidies at a Crossroads
Experts discuss what the loss of Obamacare subsidies means to patients and costs within the ACA insurance marketplace.